Looking to cash in on the market for RNAi libraries, a small biotech company called SomaGenics has begun developing siRNA libraries that are specifically designed to increase the ease with which scientists can select the most effective gene expression inhibitors.

“We focused on the need to make combinatorial libraries of inhibitors based on nucleic acids and select from those libraries therapeutic molecules that work best within the cell,” Brian Johnston, president, CEO, and founder of SomaGenics, told RNAi News.